How to read: Every bubble is one Indian voriconazole exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Voriconazole report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial voriconazole trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian voriconazole suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Voriconazole India trade report
P
Product scope
Voriconazole
All variants merged — branded and generic formulations of voriconazole
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
140
Every commercial voriconazole trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $358.7K, Nov $757.5K, Dec $283.5K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$358.7K
Oct USD
12 shipments
2
$757.5K
Nov USD
+111.2% MoM
3
$283.5K
Dec USD
-62.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 111.2% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $359K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MSN LABORATORIES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import voriconazole from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 27.7% of India’s 2025-Q4 voriconazole trade ($388.0K). Beyond the top 10 destinations, 41 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 41 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much voriconazole India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$505K
36.1% of trade
14 countries · 79 shipments
Europe
$130K
9.3% of trade
8 countries · 16 shipments
Americas
$681K
48.7% of trade
11 countries · 26 shipments
Africa
$20K
1.5% of trade
8 countries · 17 shipments
Oceania
$64K
4.6% of trade
1 countries · 2 shipments
Fig 4.1 United States is the #1 corridor ($388K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian voriconazole it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$388K
9
SANDOZ PVT LTD
$121K
ZYDUS LIFESCIENCES LTD
$121K
AJANTA PHARMA LTD
$78K
2
China
$369K
5
SANDOZ PVT LTD
$369K
—
—
—
—
3
Canada
$94K
1
UNISON PHARMACEUTICALS PVT LTD
$94K
—
—
—
—
4
Brazil
$94K
5
MSN LABORATORIES PVT LTD
$94K
INTAS PHARMACEUTICALS LTD
$2
HETERO LABS LTD
$1
5
Hong Kong
$84K
1
INTAS PHARMACEUTICALS LTD
$84K
—
—
—
—
6
Australia
$64K
2
SANDOZ PVT LTD
$63K
MYLAN LABORATORIES LTD
$451
—
—
7
Netherlands
$50K
4
MYLAN LABORATORIES LTD
$50K
—
—
—
—
8
Chile
$45K
2
MSN LABORATORIES PVT LTD
$45K
—
—
—
—
9
Russia
$43K
1
HIGLANCE LABORATORIES PVT LTD
$43K
—
—
—
—
10
Sri Lanka
$30K
6
UNITED BIOTECH PVT LTD
$28K
MANKIND PHARMA LTD
$2K
MEDMALL PHARMACY PVT LTD
$248
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 36.1% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
27.7%
#1 country share
United States alone
73.6%
Top 5 share
5 of 42 countries
96.6%
Top 15 share
Long tail of 27 countries = 3.4%
HHI 1659
Destination HHI
Moderately concentrated
42
Countries served
Global pharma reach from India
14
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
47 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYSANDOZ PVT LTD ($554.1K, 39.6% share) and MSN LABORATORIES PVT LTD ($176.1K) together control 52.2% of India’s 2025-Q4 voriconazole trade. The top 5 suppliers hold 73.7%. 47 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian voriconazole suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SANDOZ PVT LTD leads by $378K over MSN LABORATORIES PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: BAKER & DAVIS is #15 by value but #3 by volume.
Fig 5.2 MYLAN LABORATORIES LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: BAKER & DAVIS moves from #3 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 47 voriconazole suppliers split into strategic segments
KEY TAKEAWAY12 suppliers (25%) generate 97.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SANDOZ PVT LTD and MSN LABORATORIES PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.8% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
54 importers across 42 countries — who is buying Indian voriconazole and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 86.5% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian voriconazole. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 ASPEN (GUANG DONG) is the #1 importer at $369K (26.4%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian voriconazole prices vary by supplier, country and dosage form
KEY TAKEAWAYVoriconazole prices span 9315× ($0.0033 → $31.18). The coefficient of variation is 1.30. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ZYDUS LIFESCIENCES LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SANDOZ PVT LTDSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. AURO INDIASourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. UNISON PHARMACEUTICALS PVTSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Nov 2025
HIGLANCE LABORAT…
Russia
Tablet
1K
$43K
$33.27
Specialty / small-batch
Nov 2025
SANDOZ PVT LTD
Australia
—
2K
$63K
$31.18
Specialty / small-batch
Dec 2025
UNISON PHARMACEU…
Canada
Tablet
3K
$94K
$30.46
Specialty / small-batch
Oct 2025
MSN LABORATORIES…
Kenya
Tablet
480
$12K
$25.86
Specialty / small-batch
Oct 2025
ANNORA PHARMA PV…
United States
Solution
3K
$66K
$24.46
Specialty / small-batch
Dec 2025
SWASTHYA HEALTHC…
Bolivia
Injection
300
$7K
$23.79
Sterile formulation premium
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
3
$70.16
$23.39
Specialty / small-batch
Dec 2025
NAMAN PHARMA DRUGS
Kenya
Tablet
100
$2K
$20.50
Specialty / small-batch
Nov 2025
SANDOZ PVT LTD
China
—
4K
$76K
$19.27
Specialty / small-batch
Nov 2025
SANDOZ PVT LTD
China
—
4K
$72K
$19.27
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
MYLAN LABORATORI…
Australia
Tablet
139K
$451.35
$0.0032
Bulk generic tablet
Dec 2025
MYLAN LABORATORI…
France
Tablet
12K
$39.09
$0.0033
Bulk generic tablet
Dec 2025
INTAS PHARMACEUT…
Brazil
Tablet
300
$2.39
$0.0080
Bulk generic tablet
Dec 2025
MYLAN LABORATORI…
France
Tablet
44K
$481.85
$0.011
Dec 2025
MYLAN LABORATORI…
Italy
Tablet
36K
$393.39
$0.011
Dec 2025
RELICURE HEALTHC…
Iraq
Tablet
270
$5.99
$0.022
Small sample / trial shipment
Dec 2025
AL-ROYAL PHARMAC…
Egypt
Tablet
1K
$22.55
$0.023
Dec 2025
DISTINCT IMPEX P…
Iraq
Injection
300
$7.28
$0.024
Sterile formulation premium
Dec 2025
DISTINCT IMPEX P…
Iraq
Injection
300
$7.28
$0.024
Sterile formulation premium
Dec 2025
RMPL PHARMA LLP
Lebanon
Tablet
100
$2.87
$0.029
Small sample / trial shipment
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship voriconazole, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYVoriconazole leaves India through 10+ ports. The top 5 (MUMBAI AIR (SAHAR), NHAVA SHEVA SEA (JNPT), AHMEDABAD AIR) handle 82.7% of total USD. AIR moves 82% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $437K — top 10 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYAIR dominates at 82% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$833K
59.5% of USD · 82.1% of ships
SEA
$419K
29.9% of USD · 13.6% of ships
ICD
$148K
10.6% of USD · 4.3% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Asia ($371K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYChina is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 2573).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 China (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 2,573) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
ASPEN (GUANG DONG)
China
SANDOZ PVT LTD
$369K
5
HIGH
SANDOZ INC
United States
SANDOZ PVT LTD
$121K
1
HIGH
EVERSANA LIFE SCIENC…
United States
ZYDUS LIFESCIENC…
$121K
2
HIGH
JAMP PHARMA CORP
Canada
UNISON PHARMACEU…
$94K
1
MEDIUM
DRREDDYS FARMACEUTIC…
Brazil
MSN LABORATORIES…
$94K
3
MEDIUM
MCKESSON THIRD PARTY…
United States
AJANTA PHARMA LTD
$78K
4
MEDIUM
SANDOZ PTY LTD
Australia
SANDOZ PVT LTD
$63K
1
MEDIUM
MSN LABS CHILE SPA
Chile
MSN LABORATORIES…
$45K
2
MEDIUM
Conclusion: 51 buyers depend on exactly one Indian supplier, representing $1.2M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
ZMC EXPRESS CARGO FZCO
United Arab Emirates
3
$777
ALBASEL EXPORT…
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
China
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Canada
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Brazil
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Hong Kong
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Australia
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Netherlands
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Chile
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Russia
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Colombia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Italy
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Honduras
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in China
This Q
HIGH
A2
Offer alternative to ZMC EXPRESS
This Q
HIGH
A3
Audit China lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (5 suppliers)
This Q
HIGH
A6
Enter China (1 suppliers)
This Q
MED
A8
Build China distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
5
$388K
-83.5%
LOW
Low competition (5 suppliers), accessible market
2
China
Asia
1
$369K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Canada
Other
1
$94K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Brazil
Other
3
$94K
-100%
LOW
Low competition (3 suppliers), accessible market
5
Hong Kong
Asia
1
$84K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Australia
Other
2
$64K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
7
Netherlands
Other
1
$50K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Chile
Other
1
$45K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Russia
Other
1
$43K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
Sri Lanka
Asia
3
$30K
-100%
LOW
Low competition (3 suppliers), accessible market
11
Colombia
Other
1
$25K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Italy
Other
1
$17K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
France
Other
1
$17K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Honduras
Other
1
$17K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Kenya
Africa
2
$14K
-83.5%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
This report covers 140 2025-Q4 Voriconazole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/voriconazole
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 140 2025-Q4 voriconazole shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian voriconazole shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
140
across all regions
TOTAL USD
$1.40M
2025-Q4 FOB value
UNITS
992.0K
tablets, capsules, etc.
SUPPLIERS
47
Indian exporters
BUYERS
54
global importers
COUNTRIES
42
destinations
§10.2 Regional breakdown
Africa
$20K
1.5%
8 ctry · 17 ships
Asia
$505K
36.1%
14 ctry · 79 ships
Europe
$130K
9.3%
8 ctry · 16 ships
Americas
$681K
48.7%
11 ctry · 26 ships
Oceania
$64K
4.6%
1 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $20K (1.5%), spanning 8 countries.
🏢
47 Indian suppliers shipped to 54 buyers across 42 countries — average shipment value $10K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 52 global voriconazole importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian voriconazole in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
ASPEN (GUANG DONG)
China
5
$369K
SANDOZ PVT LTD
Injection
2
SANDOZ INC
United States
1
$121K
SANDOZ PVT LTD
Tablet
3
EVERSANA LIFE SCIENCE SERVICES LLC
United States
2
$121K
ZYDUS LIFESCIENCES LTD
Tablet
4
JAMP PHARMA CORP
Canada
1
$94K
UNISON PHARMACEUTICA…
Tablet
5
DRREDDYS FARMACEUTICA DO BRASIL L
Brazil
3
$94K
MSN LABORATORIES PVT…
Injection
6
MCKESSON THIRD PARTY LOGISTICS
United States
4
$78K
AJANTA PHARMA LTD
Tablet
7
SANDOZ PTY LTD
Australia
1
$63K
SANDOZ PVT LTD
8
MSN LABS CHILE SPA
Chile
2
$45K
MSN LABORATORIES PVT…
Tablet
9
PHARMA GROUP LTD
Russia
1
$43K
HIGLANCE LABORATORIE…
Tablet
10
MYLAN IRELAND LTD
Netherlands
2
$34K
MYLAN LABORATORIES LTD
Tablet
11
TRADE SERVICES DFCC BANK PLC
Sri Lanka
1
$28K
UNITED BIOTECH PVT LTD
Injection
12
MSN LABS AMERICAS SAS
Colombia
2
$25K
MSN LABORATORIES PVT…
Tablet
13
VIATRIS ITALIA SRL
Italy
2
$17K
MYLAN LABORATORIES LTD
Tablet
14
SEVEN PHARMA HONDURAS S.A
Honduras
1
$17K
ASPIRO PHARMA LTD
Injection
15
MYLAN B.V
Netherlands
2
$16K
MYLAN LABORATORIES LTD
Tablet
16
SIMBA PHARMACEUTICALS LTD
Kenya
1
$12K
MSN LABORATORIES PVT…
Tablet
17
SEVEN PHARMA GUATEMALA S.A
Guatemala
1
$9K
ASPIRO PHARMA LTD
Injection
18
THE ORDER
Bolivia
1
$7K
SWASTHYA HEALTHCARE …
Injection
19
TO THE
Oman
1
$6K
AURO INDIA
Tablet
20
NIKHIL PHARMA PVT LTD
Nepal
1
$3K
UNITED BIOTECH PVT LTD
Injection
21
HEMAS PHARMACEUTICALS (PRIVATE) LIM
Sri Lanka
4
$2K
MANKIND PHARMA LTD
Injection, Tablet
22
RUBA INTERNATIONAL SERVICES LLC
United States
1
$1K
AUROLAB FOUNDATION
Tablet
23
AUTOMOBILE TRANSPORTATION SERVICES
Lebanon
2
$1K
TRIKAYA GLOBAL
Injection, Tablet
24
SUN ENTERPRISES LTD
Rwanda
1
$1K
BIOVAP PHARMA INDUST…
Injection
25
FREIGHT LINKS EXPRESS PTE LTD
Singapore
1
$950.17
AUROLAB FOUNDATION
Tablet
26
FREIGHTER MADE LOGISTICS LTD
Ghana
2
$940.64
BAKER & DAVIS PVT LTD
Tablet
27
FOR THE ORDER OF
Ghana
1
$828.53
3S PHARMACEUTICALS I…
Tablet
28
ZMC EXPRESS CARGO FZCO
United Arab Emirates
9
$777.26
ALBASEL EXPORT AND I…
Tablet, Injection
29
CENTRAL PHARMACEUTICAL JOINT
Vietnam
1
$693.40
MYLAN LABORATORIES LTD
Tablet
30
RAPATI ENTERPRISES
Singapore
2
$541.42
BAKER & DAVIS PVT LTD
Injection, Tablet
31
ASBAR ALMOSTQBAL
Iraq
1
$533.03
RELICURE HEALTHCARE
Tablet
32
ALPHAPHARM PTY LTD
Australia
1
$451.35
MYLAN LABORATORIES LTD
Tablet
33
EMIRATES POST COMPANY
United Arab Emirates
15
$418.83
DERRIC WOOD
Tablet
34
DURRA KURDISTAN COMPANY
Iraq
1
$342.92
AUROLAB FOUNDATION
Capsule
35
ARROW TRADING FZE
United Arab Emirates
2
$328.04
BAKER & DAVIS PVT LTD
Tablet
36
NIKHOMA HOSPITAL EYE PROGRAMME
Malawi
1
$311.59
AUROLAB FOUNDATION
Other
37
PRISM INTERNATIONAL LLC
Sri Lanka
1
$248.40
MEDMALL PHARMACY PVT…
Tablet
38
AL-NOOR FOR DRUGS & MEDICAL APPLIAN
Yemen
2
$237.97
J.A. UNITED EXPORTS …
Tablet
39
SUCCESS INTER LINK PTE LTD
Singapore
2
$153.06
SANITAS MEDTECH INST…
Tablet
40
NATIONAL DRUG SERVICE ORGANIZATION
Lesotho
1
$97.34
ACT LIFESCIENCES PVT…
Tablet
41
SCN ULUSLARARASI TASIMACILIK
Turkey
1
$82.25
LOB INTERNATIONAL
Injection
42
OUMAR KONE
Mali
1
$44.35
KHATU ENTERPRISES
Injection
43
TULSI CHANDRAI FOUNDATION
Nigeria
1
$42.79
AUROLAB FOUNDATION
44
IMPERIAL PHOENIX CO LTD
Myanmar
1
$30.00
DECINA PHARMA PVT LTD
Injection
45
EUROFINS BIOPHARMA PRODUCT TESTING
Hungary
1
$22.94
INTAS PHARMACEUTICAL…
Powder
46
ROYAL PHARMA COMPANY
Egypt
1
$22.55
AL-ROYAL PHARMACEUTI…
Tablet
47
SANFARM-PRIM SA
Moldova
1
$17.96
UNITED BIOTECH PVT LTD
Tablet
48
AS PER INVOICE GHANA
Ghana
1
$6.83
VAMA HEALTH WORLD LLP
Tablet
49
ZHARAWA LTD
Iraq
1
$5.99
RELICURE HEALTHCARE
Tablet
50
ACCORD FARMACEUTICA LTDA
Brazil
1
$2.39
INTAS PHARMACEUTICAL…
Tablet
51
DONNA AMEER (BSO)
Jamaica
1
$1.78
JEEDNYA PHARMA
Tablet
52
CAMBER FARMACEUTICA LTDA
Brazil
1
$0.508
HETERO LABS LTD
This report covers 140 2025-Q4 Voriconazole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/voriconazole
Talk to our trade analyst
Need a custom voriconazole report or a deeper dive into any market? Our team is ready.